Arcturus Therapeutics – Patient Worthy

Source: Pixabay

CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency

Post author:Meagan Fulps
Post published:January 14, 2018
Post category:Rare Disease Urea cycle disorders

Another successful partnership in the rare disease community has come to fruition, reports The Pharma Letter. Just this past week, CureVac and Arcturus Therapeutics will become a powerhouse together with…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More